174 related items for PubMed ID: 25518414
1. [Steroid pulse therapy].
Miura M.
Nihon Rinsho; 2014 Sep; 72(9):1631-5. PubMed ID: 25518414
[Abstract] [Full Text] [Related]
2. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
Furukawa T, Kishiro M, Akimoto K, Nagata S, Shimizu T, Yamashiro Y.
Arch Dis Child; 2008 Feb; 93(2):142-6. PubMed ID: 17962370
[Abstract] [Full Text] [Related]
3. [Methylprednisolone pulse therapy in Kawasaki disease].
Miura M, Matsuoka M, Kohno K, Ohki H, Yoshiba S.
Nihon Rinsho; 2008 Feb; 66(2):338-42. PubMed ID: 18265457
[Abstract] [Full Text] [Related]
4. Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy.
Hashino K, Ishii M, Iemura M, Akagi T, Kato H.
Pediatr Int; 2001 Jun; 43(3):211-7. PubMed ID: 11380911
[Abstract] [Full Text] [Related]
5. Indirect-comparison meta-analysis of treatment options for patients with refractory Kawasaki disease.
Chan H, Chi H, You H, Wang M, Zhang G, Yang H, Li Q.
BMC Pediatr; 2019 May 17; 19(1):158. PubMed ID: 31101091
[Abstract] [Full Text] [Related]
6. Corticosteroid pulse combination therapy for refractory Kawasaki disease: a randomized trial.
Ogata S, Ogihara Y, Honda T, Kon S, Akiyama K, Ishii M.
Pediatrics; 2012 Jan 17; 129(1):e17-23. PubMed ID: 22144699
[Abstract] [Full Text] [Related]
7. Methylprednisolone pulse therapy for massive lymphadenopathy in a child with intravenous immunoglobulin-resistant Kawasaki disease.
Chen HH, Liu PM, Bong CN, Wu YT, Yang KD, Wang CL.
J Microbiol Immunol Infect; 2005 Apr 17; 38(2):149-52. PubMed ID: 15843862
[Abstract] [Full Text] [Related]
8. Corticosteroids in the initial treatment of Kawasaki disease: report of a randomized trial.
Sundel RP, Baker AL, Fulton DR, Newburger JW.
J Pediatr; 2003 Jun 17; 142(6):611-6. PubMed ID: 12838187
[Abstract] [Full Text] [Related]
9. Comparison of second-line therapy in IVIg-refractory Kawasaki disease: a systematic review.
Crayne CB, Mitchell C, Beukelman T.
Pediatr Rheumatol Online J; 2019 Nov 27; 17(1):77. PubMed ID: 31775898
[Abstract] [Full Text] [Related]
10. Effects of methylprednisolone pulse on cytokine levels in Kawasaki disease patients unresponsive to intravenous immunoglobulin.
Miura M, Kohno K, Ohki H, Yoshiba S, Sugaya A, Satoh M.
Eur J Pediatr; 2008 Oct 27; 167(10):1119-23. PubMed ID: 18175148
[Abstract] [Full Text] [Related]
11. The strategy of immune globulin resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy.
Ogata S, Bando Y, Kimura S, Ando H, Nakahata Y, Ogihara Y, Kaneko T, Minoura K, Kaida M, Yokota Y, Furukawa S, Ishii M.
J Cardiol; 2009 Feb 27; 53(1):15-9. PubMed ID: 19167633
[Abstract] [Full Text] [Related]
12. Clinical score and transcript abundance patterns identify Kawasaki disease patients who may benefit from addition of methylprednisolone.
Ogata S, Ogihara Y, Nomoto K, Akiyama K, Nakahata Y, Sato K, Minoura K, Kokubo K, Kobayashi H, Ishii M.
Pediatr Res; 2009 Nov 27; 66(5):577-84. PubMed ID: 19680167
[Abstract] [Full Text] [Related]
13. Pulse methylprednisolone therapy in the treatment of immune globulin-resistant Kawasaki disease: case report and review of the literature.
Hung JJ, Chiu CH.
Ann Trop Paediatr; 2004 Mar 27; 24(1):89-93. PubMed ID: 15005973
[Abstract] [Full Text] [Related]
14. Frequency and time to relapse after discontinuing 6-month therapy with IVIg or pulsed methylprednisolone in CIDP.
Nobile-Orazio E, Cocito D, Jann S, Uncini A, Messina P, Antonini G, Fazio R, Gallia F, Schenone A, Francia A, Pareyson D, Santoro L, Tamburin S, Cavaletti G, Giannini F, Sabatelli M, Beghi E, IMC Trial Group.
J Neurol Neurosurg Psychiatry; 2015 Jul 27; 86(7):729-34. PubMed ID: 25246645
[Abstract] [Full Text] [Related]
15. Management and outcome of intravenous gammaglobulin-resistant Kawasaki disease.
Sittiwangkul R, Pongprot Y, Silvilairat S, Phornphutkul C.
Singapore Med J; 2006 Sep 27; 47(9):780-4. PubMed ID: 16924360
[Abstract] [Full Text] [Related]
16. [Immunoglobulin therapy].
Ogata S, Ishii M.
Nihon Rinsho; 2014 Sep 27; 72(9):1617-22. PubMed ID: 25518412
[Abstract] [Full Text] [Related]
17. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
Hsieh KS, Weng KP, Lin CC, Huang TC, Lee CL, Huang SM.
Pediatrics; 2004 Dec 27; 114(6):e689-93. PubMed ID: 15545617
[Abstract] [Full Text] [Related]
18. Role of glucocorticoids in Kawasaki disease.
Miura M.
Int J Rheum Dis; 2018 Jan 27; 21(1):70-75. PubMed ID: 29105310
[Abstract] [Full Text] [Related]
19. Massive lymphadenopathy and airway obstruction in a child with Kawasaki disease: success with pulse steroid therapy.
Shetty AK, Homsi O, Ward K, Gedalia A.
J Rheumatol; 1998 Jun 27; 25(6):1215-7. PubMed ID: 9632089
[Abstract] [Full Text] [Related]
20. Steroid pulse therapy for children with intravenous immunoglobulin therapy-resistant Kawasaki disease: a prospective study.
Teraguchi M, Ogino H, Yoshimura K, Taniuchi S, Kino M, Okazaki H, Kaneko K.
Pediatr Cardiol; 2013 Apr 27; 34(4):959-63. PubMed ID: 23184018
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
